Navigation Links
Telik Announces Receipt of Nasdaq Notice
Date:9/25/2008

PALO ALTO, Calif., Sept. 25 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK) today announced that on September 19, 2008 it received from The Nasdaq Stock Market, or Nasdaq, a deficiency notice letter indicating that for the last 30 consecutive business days the bid price of Telik's common stock has closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Global Market under Marketplace Rule 4450(a)(5). In accordance with Marketplace Rule 4450(e)(2), Telik has 180 calendar days, or until March 18, 2009, to regain compliance. If at any time before March 18, 2009 the bid price of Telik's common stock closes at $1.00 per share or more for at least ten consecutive business days, Nasdaq will provide written notification that Telik has achieved compliance. Nasdaq may also require Telik to maintain a closing bid price of at least $1.00 per share for a longer period before determining that Telik has achieved compliance. If Telik does not regain compliance by March 18, 2009, Nasdaq would provide written notification that Telik's common stock will be delisted, after which Telik may appeal to the Nasdaq Listing Qualifications Panel.

About Telik

Telik, Inc. of Palo Alto, CA, is a biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. The company's most advanced investigational drug candidates in clinical development are TELINTRA(R), a modified glutathione analog for the treatment of cytopenias due to myelodysplastic syndrome or chemotherapy, and TELCYTA(R), a tumor-activated prodrug for the treatment of advanced ovarian cancer and non-small cell lung cancer. Telik's product candidates were discovered using its proprietary
'/>"/>

SOURCE Telik, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Telik Announces Presentation and Webcast at Bear Stearns Healthcare Conference
2. Telik Announces Presentation and Webcast at UBS Global Life Sciences Conference
3. Telik Announces Presentation and Webcast at JPMorgan Healthcare Conference
4. Telik Announces Year-End Financial Release, Conference Call and Webcast
5. Telik Announces Revised Date for Year-End Financial Release, Conference Call and Webcast
6. Telik Announces Fourth Quarter and 2007 Year End Financial Results and 2008 Guidance
7. Telik Presents Preclinical Data at 99th Annual Meeting of the American Association for Cancer Research
8. Telik Announces First Quarter 2008 Financial Results
9. Telik Announces Presentation and Webcast at Needham Biotechnology Conference
10. Telik Announces Publication of Diabetes Research in Bioorganic & Medicinal Chemistry Letters
11. Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... Global HIV Infection Drug Market and ... Reportstack. The rate of HIV infection and the number of ... at a positive rate across the globe. It has been ... 2005 to 1.5 in 2013, with the rates for children ... changes in the infection rates has been the improved access ...
(Date:8/18/2014)... , Aug. 18, 2014 TNI BioTech, ... company pioneering the manufacturing and marketing of innovative therapies ... the Company is providing a second notice of TNI ... In making the announcement, Noreen Griffin , founder ... in advance for your participation in the Annual Meeting. ...
(Date:8/18/2014)... , 18. August 2014 Vier ... eine internationale klinische Studie auf, in der ... Linse soll das Sehvermögen bei allen Entfernungen ... Operation möglicherweise keine Lese- oder Gleitsichtbrille mehr ... Namen FluidVision Accommodating Intraocular Lens ...
(Date:8/16/2014)... Laser physicists have found a way to make atomic-force ... detecting forces as small as the weight of an ... The Australian National University (ANU), hinges on using laser ... degrees Celsius. , "The level of sensitivity achieved after ... weight of a large virus that is 100 billion ...
Breaking Biology Technology:Global HIV Infection Drug Market Overview 2Global HIV Infection Drug Market Overview 3Global HIV Infection Drug Market Overview 4TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 2TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 3TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 4Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 2Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 3Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 4Laser makes microscopes way cooler 2
... - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY ... investment in British Canadian Biosciences Corp. (BCBC), a privately ... for the treatment of a variety of conditions, including ... preferred shares of BCBC in exchange for 200,000 common ...
... The Case Western Reserve University Biomedical Engineering Department ... benefiting newborns and the aged, the critically ill and ... the future as it celebrates its 40th anniversary, Thursday, ... first universities in the nation to offer graduate and ...
... HARRISBURG, Pa., Oct. 20 PresentCare, a technology ... AdherencePlus(TM) solution, an innovative approach to assist the ... medication non-adherence. The AdherencePlus solution is comprised ... communication technology combined with unprecedented human touch. Both ...
Cached Biology Technology:Oncolytics Biotech(R) Inc. Announces Investment in Private Biotechnology Company 240 Years on the Leading Edge: Case Western Reserve University's Biomedical Engineering Department Commemorates Achievement, Looks to Future 2Medication Adherence Technology Combines with Patient Outreach Program to Yield Healthier Populations and Reduce Healthcare Costs 2Medication Adherence Technology Combines with Patient Outreach Program to Yield Healthier Populations and Reduce Healthcare Costs 3
(Date:8/19/2014)... of Texas Health Science Center at San Antonio and ... announced the awarding of more than $750,000 in grants ... Challenge. , Launched in 2003, SALSI is a model ... academic health science center join forces for greater research ... studies, with a focus on public health issues and ...
(Date:8/19/2014)... a nearly $40,000 grant from the National Center for ... National Park Service (NPS) and U.S. Department of the ... the energy efficiency and cost effectiveness of radiant barrier ... Radiant barriers are reflective thermal insulations commonly fitted into ... the amount of heat emitted in the direction of ...
(Date:8/19/2014)... Rochelle, August 19, 2014A new ovoid structure discovered in ... clay, contains a variety of minerals, and shows evidence ... resulting melting of the permafrost and mixing of surface ... broad range of analytical studies to determine the origin ... for how this ovoid formed, point to the most ...
Breaking Biology News(10 mins):San Antonio Life Sciences Institute awards $750,000 to innovators 2San Antonio Life Sciences Institute awards $750,000 to innovators 3UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 2UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 3Life on Mars? Implications of a newly discovered mineral-rich structure 2
... An alliance of top researchers at the University of ... Institute (SBI), advancing efforts to engineer cells and biological ... health and medicine, energy, the environment, new materials, and ... new institute aiming to create "an industrial revolution ...
... special mechanisms that delay ageing provide exceptionally good health. ... colony-forming ascidians (or sea squirts) can activate the enzyme ... also in humans who attain an advanced age. , ... individual,s body is passes on to the next generations, ...
... oximetry training video produced by Rafael Ortega, MD, the ... at Boston Medical Center (BMC) and professor of anesthesiology ... colleagues is featured in this week,s New England ... which is the fifth BMC-produced video to appear in ...
Cached Biology News:UC Berkeley launches Synthetic Biology Institute to advance research in biological engineering 2UC Berkeley launches Synthetic Biology Institute to advance research in biological engineering 3Marine organisms with eternal life can solve the riddle of aging 2Pulse oximetry training video by BMC anesthesiologist published in NEJM 2
Rabbit Anti-Human Janus Kinase 2 (JAK2 Polyclonal Antibody Family: Protein Kinase Sub-Family: TYK2/JAK Applications: ELISA, Western Blot...
MAb to HSV-2, gG-2 HSV-2 Glycoprotein G-2...
Immunogen for A300-655A was a phosphorylated synthetic peptide, which represented a portion of human RNA Polymerase II (GeneID 5430) around serine 5 of the C-terminal repeat YSPTSPS....
human Exodus-2 Research Focus: cytokine/growth factor Storage Temperature: -20C Shipping Temperature: 4C...
Biology Products: